Max Healthcare Institute Ltd

Q3 FY26Healthcare Services

Max Healthcare Institute Q3 FY26 earnings call: Revenue & Margins

Q3 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,000

Market cap₹98.2K Cr

P/E65.6

Updated23 Aug 2026

Read5 min read

The short version

Network gross revenue grew 19% YoY in nine months ended Dec 2025, indicating strong growth momentum. Growth is expected to resume strongly from Q4 FY '26 onwards as capacity constraints ease and new hospital beds come online.

From Max Healthcare Institute Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

Network gross revenue grew 19% YoY in nine months ended Dec 2025, indicating strong growth momentum.
Existing beds are growing at low teens percentage rates, partly due to higher onco share and advanced services like robotics.
Capacity additions have faced minor delays but are expected to drive growth once operational (e.g., Dwarka expansion by 260 beds, Gurgaon hospital commissioning by H1 FY '27, Zirakpur by FY '28).
Institutional patient mix increased temporarily due to insurance disruptions but is normalizing, with cashless services restored.
ARPOB growth is moderate (3% YoY), reflecting stable pricing with medical inflation in low single digits.

2 more points management made on revenue & sales performance

Profitability & Margins

Growth is expected to resume strongly from Q4 FY '26 onwards as capacity constraints ease and new hospital beds come online.
Addition of 1,200 beds including Gurgaon will raise operational beds to ~6,000 by FY '26 and ~8,000 by FY '28, as per updated presentation.
Incremental capacity additions are EBITDA and margin accretive, with new facilities like Nanavati and Saket already contributing positively.
Institutional patient mix has temporarily increased due to insurance disruptions but is expected to normalize, improving profitability.
Upward revision in CGHS tariffs anticipated to fully kick in by April 2026, supporting margins.
Focus is on Return on Capital Employed (ROCE) over EBITDA per bed, aiming for efficient capital deployment.

2 more points management made on profitability & margins

See what Max Healthcare Institute Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Current capex run rate is roughly INR 400-450 crore per quarter.
FY '26 capex target is around INR 1,900 crore; the company is on track to meet this.
Capex is mostly back-ended, with conservative projections to avoid project delays due to financial closure.
Capex plans will be revisited by end of March 2025 with possible updates.
Incremental beds being commissioned are EBITDA and margin accretive, improving future cash flows.
Expansion projects underway:
Max Lucknow increasing capacity from 413 to ~500 beds by FY '26-end.
Gurgaon 500-bed hospital expected first phase commissioning by end H1 FY '27.
100 beds at Nagpur with civil work started, targeted completion in 24 months.
400 beds at Zirakpur (Mohali) on track for FY '28 commission.
200 beds at Max Vaishali awaiting approvals, completion within 24 months post-approval.

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹919 Cr

Rev 1Mar 1

2Chandan Healthca₹590 Cr

Rev 1Mar 3

3₹66.2K Cr

Rev 2Mar 1

4₹1.8K Cr

Rev 2Mar 2

5₹649 Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The company expects incremental net debt to increase by around INR 500-600 crore in the near term (page 20).
Net debt is projected to remain below a ratio of 1 unless an M&A activity occurs (page 20).
Capex guidance for FY '26 is approximately INR 1,900 crore, with current capex run rate around INR 400 crore per quarter (page 20).
Management mentions that capex numbers are conservative and will be revisited at the end of March 2025 (page 20).
The company expects better cash flows from new beds coming online, which will support operating margins (page 20).

2 more points management made on fundraising & capital structure

See what Max Healthcare Institute Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not specifically mention the current or expected order book or pending orders for Max Healthcare. However, it provides detailed information on bed capacity expansions and projects underway: - Adding approximately 1,200 beds including Gurgaon currently with around 4,800 operational beds. - Expected to reach around 6,000 beds soon and target of 8,000 beds by FY '28, further details available in the presentation. - Expansion projects underway: - Max Lucknow: Increasing capacity to 500 beds by year-end. - Gurgaon: 500 beds, first phase commissioning expected by end of H1 FY '27. - Nagpur: 100 beds project started, expected to complete in 24 months. - Zirakpur (Mohali): 400 beds, commissioning planned in FY '28.

2 more points management made on order book & pipeline

Max Healthcare Institute Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹2.1K Cr, net profit ₹342 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Max Healthcare's management said in earlier quarters

Others in Healthcare Services this season

Vijaya Diagnost. (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnost.'s Q3 FY26 earnings call — and…
Aster DM Quality (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
Chandan Healthcare Ltd (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
Rainbow Child. (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…

Compare:vs Apollo Hospitals Enterprise Ltd vs Manipal Health vs Aster DM Quality

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Max Healthcare Institute Ltd Q3 FY26 results?

What is Max Healthcare Institute Ltd share price analysis?

Max Healthcare Institute Ltd currently shows a neutral. The stock trades at a P/E of 65.6 with a market cap of ₹98,161 Cr. Investors should review the full earnings analysis for detailed insights.

Is Max Healthcare Institute Ltd planning capital expenditure?

Current capex run rate is roughly INR 400-450 crore per quarter.

Keep Max Healthcare Institute Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.